Denys Goloshchapov, MD
Interventional Pain Medicine · Las Vegas, NVNPI 1649687914
Payments from drug & device makers
What this record shows
This record is dominated by grants: $6,666 of the $10,807 with a category attached, or 61.7%. 14 manufacturers reported payments, led by Medtronic at 49.0% of the total. Reporting peaked in 2020 at $7,108 and has fallen 85.3% since, to $1,042 in 2025.
Across 95 payments — averaging $113.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$2K
- Nevro Corp.$1K
- Abbott$678
- Globus Medical$443
- Nalu Medical, Inc.$240
- plus $484 from 8 others
What the payments were for
- Grants$6,66662%
- Food & beverage$4,14138%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 3 | $5,291 |
| Boston Scientific | 28 | $2,290 |
| Nevro Corp. | 22 | $1,382 |
| Abbott | 12 | $678 |
| Globus Medical | 4 | $443 |
| Nalu Medical, Inc. | 7 | $240 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $97 |
| AbbVie | 4 | $93 |
| Vertos Medical, Inc. | 2 | $91 |
| Lilly USA, LLC | 4 | $63 |
| Si-bone, Inc. | 1 | $55 |
| Sonex Health, Inc. | 1 | $42 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Curonix LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$5,000
- SPECTRA WAVEWRITER$1,666
- Senza$532
- Omnia$355
- Senza Spinal Cord Stimulation System$343
- PENTA$256
- INCEPTIV$162
- GENERAL PAIN MANAGEMENT$151
- INTELLIS$129
- Proclaim IPG$109
How this compares
$10,807 in reported general payments places this provider in the 75th percentile of 32 interventional pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Las Vegas
- Adam AntflickLas Vegas$26K
- Stephen GephardtLas Vegas$14K
- Jeremy LipshutzLas Vegas$13K
- Edson ErkulvrawatrLas Vegas$6K
- Alafuro OrueneLas Vegas$6K
- Dolue EzeanolueLas Vegas$5K
- Katherine TravnicekLas Vegas$5K
- Godwin MadukaLas Vegas$4K
- Daniel BurkheadLas Vegas$4K
- Haroon AndarLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.